Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?

Raffaele Bruno; Stefano Fagiuoli; Paolo Sacchi

doi:10.1586/eri.11.85

Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?

Raffaele Bruno, Stefano Fagiuoli, Paolo Sacchi

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	699-701
Number of pages	3
Journal	Expert Review of Anti-Infective Therapy
Volume	9
Issue number	9
DOIs	https://doi.org/10.1586/eri.11.85
Publication status	Published - Sep 2011

Keywords

antiretroviral therapy
boceprevir
DAA
DAA-resistance
HIV-HCV coinfection
pharmacokinetic interactions
telaprevir

ASJC Scopus subject areas

Infectious Diseases
Microbiology (medical)
Microbiology
Virology

Access to Document

10.1586/eri.11.85

Cite this

@article{2e82d77f59d1456cbe6a1a6463c4b774,

title = "Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?",

keywords = "antiretroviral therapy, boceprevir, DAA, DAA-resistance, HIV-HCV coinfection, pharmacokinetic interactions, telaprevir",

author = "Raffaele Bruno and Stefano Fagiuoli and Paolo Sacchi",

year = "2011",

month = sep,

doi = "10.1586/eri.11.85",

language = "English",

volume = "9",

pages = "699--701",

journal = "Expert Review of Anti-Infective Therapy",

issn = "1478-7210",